Average Glucose to HbA1c: UK Guide

Average glucose to HbA1c conversion is a key concept for anyone managing or monitoring blood sugar levels in the UK. Average glucose, measured in mmol/L, reflects day-to-day fluctuations captured by a glucose meter or continuous glucose monitor, while HbA1c provides a longer-term picture of glycaemic control over two to three months. Understanding how these two measures relate to each other helps you interpret your results, set meaningful targets, and have more informed conversations with your GP or diabetes care team.

What is the difference between average glucose and HbA1c?

Average glucose reflects mean blood sugar readings across daily activities in mmol/L, while HbA1c measures glycated haemoglobin over two to three months and is reported in mmol/mol in the UK. The two measures are complementary and used together to assess glycaemic control.

Average glucose and HbA1c measure blood sugar in fundamentally different ways, and understanding the distinction helps you interpret your results more accurately. Average glucose, often expressed in millimoles per litre (mmol/L), reflects the mean of multiple blood glucose readings taken at different times of day, typically captured by a glucose meter or continuous glucose monitor (CGM). It gives a snapshot of how blood sugar fluctuates across daily activities, meals and sleep.

HbA1c, by contrast, is a laboratory blood test that measures the proportion of haemoglobin in red blood cells that has become glycated, meaning glucose has attached to it. Because red blood cells survive for roughly 90 to 120 days, HbA1c reflects average blood glucose exposure over approximately the preceding two to three months.^[12][7] In the UK, HbA1c is reported using the IFCC scale in millimoles per mole (mmol/mol).^[12][2] Older resources and some international references use the DCCT percentage scale; the two scales are not interchangeable, and UK laboratory reports now use mmol/mol as standard.

The two measures are complementary rather than interchangeable. Average glucose readings can reveal patterns, such as post-meal spikes or overnight lows, that HbA1c cannot capture. HbA1c, on the other hand, provides a longer-term summary that is less susceptible to day-to-day variation. Clinicians typically use both together to build a fuller picture of glycaemic control, particularly when managing type 2 diabetes or monitoring people at risk of developing it.

How does your average blood sugar level convert to an HbA1c result?

An HbA1c of 48 mmol/mol corresponds to an estimated average glucose of approximately 7.8 mmol/L, using the validated ADAG conversion formula. These are population-level estimates and individual results should be interpreted with a healthcare professional.

Your average blood glucose level can be estimated from an HbA1c result using a validated conversion formula, and conversely, an HbA1c can be translated back into an estimated average glucose (eAG). The relationship between the two is well established through research, including the international A1c-Derived Average Glucose (ADAG) study, which demonstrated a consistent mathematical relationship across diverse populations.

The ADAG formula converts an HbA1c expressed on the DCCT percentage scale to an eAG in mg/dL, which can then be divided by 18.02 to give mmol/L. Using this approach, the approximate eAG values for key UK thresholds are:

• An HbA1c of 42 mmol/mol (approximately 6.0% on the DCCT scale), the upper limit of the pre-diabetes range, corresponds to an estimated average glucose of around 7.0 mmol/L.

• An HbA1c of 48 mmol/mol (approximately 6.5%), the diagnostic threshold for type 2 diabetes in the UK per NICE guidance (NG28), corresponds to an estimated average glucose of approximately 7.8 mmol/L.

• An HbA1c of 53 mmol/mol (approximately 7.0%), which NICE (NG28) identifies as a treatment target for people whose medicines carry a risk of hypoglycaemia, such as sulphonylureas or insulin, corresponds to an estimated average glucose of approximately 8.^[1][2]5 mmol/L.

It is important to note that these conversions are population-level estimates. Individual variation means that two people with identical average glucose readings may have slightly different HbA1c results. Diabetes UK provides an online HbA1c converter that can be useful for educational purposes, but any interpretation of your own results should be discussed with a healthcare professional. Your GP or diabetes care team can explain what your specific figures mean in the context of your overall health, treatment plan and monitoring targets.

Which factors can affect the accuracy of an HbA1c reading?

Haemolytic anaemia, iron deficiency, haemoglobin variants, recent blood transfusion and chronic kidney disease can all cause falsely high or low HbA1c results. NICE guidance (NG28) identifies specific situations where HbA1c should not be used for diagnosis.

Several medical and physiological factors can cause an HbA1c result to be falsely high or falsely low, making it an unreliable measure of average glucose in certain individuals. Clinicians are trained to recognise these situations and may request alternative tests when HbA1c is likely to be misleading. NICE guidance (NG28) sets out circumstances in which HbA1c should not be used for diagnosis.

Conditions that affect red blood cell lifespan are among the most significant sources of inaccuracy:

• Haemolytic anaemia shortens red blood cell survival, reducing the time available for glycation and producing a falsely low HbA1c.^[12][7]

• Iron deficiency anaemia can cause a falsely elevated HbA1c, as can vitamin B12 or folate deficiency.^[11][12]

• Haemoglobin variants, such as sickle cell trait or haemoglobin C, can interfere with some laboratory assays depending on the method used; the degree of interference varies by assay, and the laboratory can advise on whether an alternative method or test is needed.^[13][12]

• Recent blood transfusion introduces donor red blood cells of varying ages, distorting the result.

• Chronic kidney disease is associated with altered red blood cell turnover and can affect HbA1c reliability.

HbA1c is also not appropriate for diagnosing diabetes in certain other situations, including suspected type 1 diabetes, in children and young people, or where there has been a recent acute change in glycaemia. NICE guidance (NG3) confirms that gestational diabetes is diagnosed using oral glucose tolerance testing rather than HbA1c, because increased red blood cell turnover during pregnancy tends to lower HbA1c values.^[4][5]

In situations where HbA1c is unreliable, clinicians may use fructosamine testing, which reflects average glucose over a shorter two to three week window, or rely more heavily on continuous glucose monitoring data. If you have any of the conditions listed above, it is worth discussing with your GP whether HbA1c remains the most appropriate monitoring tool for you.

How do NHS targets for HbA1c compare to average glucose goals?

NICE recommends an HbA1c target of 48 mmol/mol for most adults with type 2 diabetes, equivalent to an estimated average glucose of around 7.8 mmol/L. Targets are individualised and may differ for those on hypoglycaemia-risk medicines, people with type 1 diabetes or during pregnancy.

NHS HbA1c targets vary depending on the individual's clinical situation, and these targets correspond to specific average glucose ranges that can help contextualise day-to-day monitoring. NICE guidance sets out different thresholds for different groups, reflecting the balance between reducing long-term complications and avoiding hypoglycaemia.

For most adults with type 2 diabetes managed with lifestyle changes or non-hypoglycaemic medications, NICE (NG28) recommends an HbA1c target of 48 mmol/mol, corresponding to an estimated average glucose of approximately 7.^[1][2]8 mmol/L. For those on medications that carry a risk of hypoglycaemia, such as sulphonylureas or insulin, the target is typically 53 mmol/mol, corresponding to an estimated average glucose of approximately 8.5 mmol/L, to reduce the risk of low blood sugar episodes. Targets should always be individualised in discussion with your care team.

For people with type 1 diabetes, NICE (NG17) recommends aiming for an HbA1c of 48 mmol/mol or below where this can be achieved safely, acknowledging that tighter control must be weighed against hypoglycaemia risk.^[3] In pregnancy complicated by pre-existing diabetes, targets are considerably stricter, with NICE (NG3) recommending an HbA1c below 48 mmol/mol before conception and as low as safely achievable during pregnancy.^[4][5]

When using a CGM or glucose meter, average glucose targets are often expressed as time in range, typically defined as the proportion of readings between 3.9 and 10.0 mmol/L. NICE and Diabetes UK both support time in range as a complementary metric alongside HbA1c, and international consensus guidance recommends that most adults with diabetes aim for at least 70% of readings within this range, though targets may differ for pregnancy or where there is a high risk of hypoglycaemia. Your diabetes care team can help you understand how your average glucose readings align with your personalised HbA1c goal, and whether your current management plan is achieving the right balance.

When should you speak to your GP about your blood sugar levels?

Speak to your GP if fasting glucose is persistently at or above 7.0 mmol/L, your HbA1c has risen, or you have symptoms of hyper- or hypoglycaemia. Call 999 immediately if you suspect diabetic ketoacidosis or hyperosmolar hyperglycaemic state.

You should speak to your GP if your blood glucose readings are consistently outside your agreed target range, if your HbA1c has risen since your last test, or if you are experiencing symptoms that may suggest poorly controlled blood sugar. Acting promptly on changes in your results can help prevent long-term complications such as nerve damage, kidney disease and cardiovascular problems.

Specific situations that warrant a GP appointment include:

• Fasting glucose readings persistently at or above 7.0 mmol/L, which falls within the diagnostic range for type 2 diabetes per NHS and NICE guidance.

• Post-meal readings regularly exceeding 11.0 mmol/L, which may indicate that your current management approach needs review.

• Symptoms of hyperglycaemia, including increased thirst, frequent urination, fatigue or blurred vision.

• Frequent hypoglycaemic episodes (blood glucose below 4.0 mmol/L), particularly if you are on insulin or a sulphonylurea. If you experience hypoglycaemia that you believe may be related to a medicine you are taking, you can report this to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

• An HbA1c result above your agreed target at your annual diabetes review.

If you are not yet diagnosed with diabetes but are concerned about your risk, your GP can arrange a fasting glucose test or HbA1c to screen for pre-diabetes (HbA1c 42 to 47 mmol/mol) or type 2 diabetes.^[6][2]

For urgent concerns, seek emergency help immediately in the following situations:

• Possible diabetic ketoacidosis (DKA): very high glucose readings accompanied by vomiting, abdominal pain, rapid or deep breathing, or confusion. DKA can affect people with type 1 diabetes and, less commonly, type 2 diabetes.

• Possible hyperosmolar hyperglycaemic state (HHS): very high glucose, severe dehydration, drowsiness or confusion, particularly in people with type 2 diabetes. HHS develops more slowly than DKA but is a medical emergency.

Call 999 or go to A&E immediately if you suspect either of these conditions. For non-emergency advice outside GP hours, NHS 111 can provide guidance.

If you are exploring structured weight management as part of improving glycaemic control, Bolt Pharmacy is a GPhC-registered online pharmacy (Great Britain) offering online consultations with prescriber review and pharmacist support, where clinically appropriate options may be considered.

Scientific References

1. Type 2 diabetes in adults: management (NG28) – Blood glucose management chapter.
2. Type 2 diabetes in adults: management (NG28).
3. Type 1 diabetes in adults: diagnosis and management (NG17) – Recommendations.
4. Diabetes in pregnancy: management from preconception to the postnatal period (NG3) – Recommendations.
5. Diabetes in pregnancy: management from preconception to the postnatal period (NG3).
6. Type 2 diabetes: prevention in people at high risk (PH38) – Recommendations.
7. Diabetes – Treatment summaries.
8. Type 2 diabetes – Treatment summaries.
9. High blood sugar (hyperglycaemia).
10. Gestational diabetes.
11. Vitamin B12 or folate deficiency anaemia.
12. Targeting HbA1c: standardization and clinical laboratory measurement. MLO: Medical Laboratory Observer.
13. A Rare Hemoglobin Variant Detected for the First Time in Türkiye (Hb Iraq-Halabja): Evaluation of the Effect of Variant Hemoglobins on HbA1c Methods.
14. Fructosamine as an Indicator for Glycemic Control in the Veteran Community. Military Medicine.

Frequently Asked Questions